Silverback Therapeutics I... (SBTX)

NASDAQ: SBTX · Real-Time Price · USD

5.87

0.06 (1.03%)

At close: Nov 09, 2022, 5:00 AM

Silverback Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Net Income	n/a	n/a	-14.96M	27.24M	-17.86M	-19.43M	-24.63M	-23.46M	-22.66M	-24.5M	-18.87M	-13.09M	-8.12M	-6.47M	-5.28M	-6.97M
Depreciation & Amortization	n/a	n/a	20K	-214K	102K	224K	207K	187K	203K	207K	186K	189K	171K	138K	139K	138K
Stock-Based Compensation	n/a	356K	2.25M	-9.28M	5.04M	5.14M	4.95M	5.15M	5.02M	4.73M	4.29M	2.27M	191K	128K	47K	42K
Other Working Capital	n/a	n/a	-4.76M	12.98M	n/a	2.21M	-331K	-9.46M	-2.02M	5.14M	-294K	-753K	452K	488K	-2.82M	583K
Other Non-Cash Items	n/a	-356K	-4.49M	-12.61M	535K	264K	249K	243K	338K	286K	281K	279K	273K	270K	282K	271K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	n/a	4.76M	6.26M	-4.39M	-1.35M	-517K	-3.43M	-2.02M	5.14M	1.91M	-753K	452K	488K	-2.82M	583K
Operating Cash Flow	n/a	356K	-12.43M	11.4M	-16.58M	-15.15M	-19.74M	-21.3M	-19.12M	-14.13M	-12.2M	-11.1M	-7.03M	-5.44M	-7.63M	-5.94M
Capital Expenditures	n/a	n/a	-193K	485K	-66K	-286K	-332K	-550K	-87K	-700K	-35K	-247K	-632K	-5K	-33K	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	-131.35M	n/a	n/a	n/a	n/a	-65.11M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	20M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	39.97M	-39.97M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	-111.55M	485K	-66K	-286K	-332K	-25.68M	-40.06M	-700K	-35K	-247K	-632K	-5K	-33K	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.46M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-846K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	1.32M	189.39M	1.18M	139K	19K	1.12M	148K	319K	-128K	255.4M	119.86M	11.93M	21.32M	9.65M
Financial Cash Flow	n/a	n/a	1.32M	189.39M	1.18M	139K	19K	275K	148K	319K	-128K	255.4M	119.86M	11.93M	21.32M	9.65M
Net Cash Flow	n/a	356K	-122.66M	7.04M	-15.47M	-15.3M	-20.06M	-46.72M	-59.03M	-14.52M	-12.36M	244.05M	112.2M	6.49M	13.65M	3.71M
Free Cash Flow	n/a	356K	-12.62M	11.88M	-16.65M	-15.44M	-20.07M	-21.86M	-19.21M	-14.84M	-12.24M	-11.34M	-7.66M	-5.45M	-7.66M	-5.94M